Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial. Preliminary report

Mariano Duarte, Facundo Pelorosso, Liliana Nicolosi, M. Victoria Salgado, Héctor Vetulli, Analía Aquieri, Francisco Azzato, Mauro Basconcel, Marcela Castro, Javier Coyle, Ignacio Davolos, Eduardo Esparza, Ignacio Fernandez Criado, Rosana Gregori, Pedro Mastrodonato, María C. Rubio, Sergio Sarquis, Fernando Wahlmann, Rodolfo P. Rothlin
doi: https://doi.org/10.1101/2020.08.04.20167205

Data Availability

Data of individual participants that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) will be made available upon publication for 5 years at a third-party website (DOI: 10.5281/zenodo.3970223)

http://10.5281/zenodo.3970223

Back to top
Posted August 11, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial. Preliminary report
Mariano Duarte, Facundo Pelorosso, Liliana Nicolosi, M. Victoria Salgado, Héctor Vetulli, Analía Aquieri, Francisco Azzato, Mauro Basconcel, Marcela Castro, Javier Coyle, Ignacio Davolos, Eduardo Esparza, Ignacio Fernandez Criado, Rosana Gregori, Pedro Mastrodonato, María C. Rubio, Sergio Sarquis, Fernando Wahlmann, Rodolfo P. Rothlin
medRxiv 2020.08.04.20167205; doi: https://doi.org/10.1101/2020.08.04.20167205
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area